Clinical Trials Directory

Trials / Conditions / Advanced Biliary Tract Carcinoma

Advanced Biliary Tract Carcinoma

12 registered clinical trials studyying Advanced Biliary Tract Carcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tum
NCT07405086
OHSU Knight Cancer InstitutePhase 2
RecruitingAdebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
NCT07392541
Tongji HospitalPhase 1 / Phase 2
RecruitingMP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract
NCT07036380
Centre Hospitalier Universitaire de BesanconPhase 2
RecruitingOlanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, He
NCT05705492
OHSU Knight Cancer InstitutePhase 2
Active Not RecruitingStudy of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A Co
NCT05564403
National Cancer Institute (NCI)Phase 2
RecruitingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
Mayo ClinicPhase 2
RecruitingCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Pati
NCT05733000
Northwestern UniversityPhase 2
Active Not RecruitingCamrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally A
NCT05451290
First Affiliated Hospital of Zhejiang UniversityPhase 2
CompletedPembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma
NCT04550624
Shanghai Jiahui International HospitalPhase 2
Active Not RecruitingDurvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.
NCT03704480
GERCOR - Multidisciplinary Oncology Cooperative GroupPhase 2
CompletedA Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC
NCT03092895
Jiangsu HengRui Medicine Co., Ltd.Phase 2
CompletedFirst Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma
NCT01828034
Memorial Sloan Kettering Cancer CenterPhase 1 / Phase 2